A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
The division cycle of eukaryotic cells is regulated by a family of protein kinases known as the cyclin-dependent kinases (CDKs). The sequential activation of individual members of this family and their consequent phosphorylation of critical substrates promotes orderly progression through the cell cycle. The complexes formed by CDK4 and the D-type cyclins have been strongly implicated in the control of cell proliferation during the G1 phase. CDK4 exists, in part, as a multi-protein complex with a D-type cyclin, proliferating cell nuclear antigen and a protein, p21 (refs 7-9). CDK4 associates separately with a protein of M(r) 16K, particularly in cells lacking a functional retinoblastoma protein. Here we report the isolation of a human p16 complementary DNA and demonstrate that p16 binds to CDK4 and inhibits the catalytic activity of the CDK4/cyclin D enzymes. p16 seems to act in a regulatory feedback circuit with CDK4, D-type cyclins and retinoblastoma protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p16, on the other hand, acts through the Retinoblastoma (Rb) pathway (Serrano et al, 1993).”
From Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues (2025) · cites this paper as Serrano et al, 1993
In the citing paper
“p16INK4A is a 16 KDa protein that directly binds to CDK4/6 and blocks the formation of cyclinD-CDK4/6 complexes, thereby preventing phosphorylation of RB and promoting expression of E2F target genes (Serrano et al., 1993).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Serrano et al., 1993
In the citing paper
“This member of the INK4a family is a cyclin D-dependent kinase CDK4 and CDK6 inhibitor, which prevents the phosphorylation of the retinoblastoma protein (Rb), therefore leading to suspension of the cell cycle before the S-phase [78,79].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [78]
In the citing paper
“Currently, p16Ink4a is one of the widely used markers for studying cellular senescence, and it plays a prominent role in inhibiting CDK4/6 and restricting the progression of G1 to S phase in the cell cycle.16,17”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [16]
In the citing paper
“Currently, p16Ink4a is one of the widely used markers for studying cellular senescence, and it plays a prominent role in inhibiting CDK4/6 and restricting the progression of G1 to S phase in the cell cycle.16,17”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [16]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
A novel genetic system to detect protein–protein interactions
Fields, S., & Song, O.-K. (1989) · Nature · doi:10.1038/340245a0 · Cited by 6,114
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Self-citationSherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021
Self-citationFunctional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
A family of human cdc2-related protein kinases.
Meyerson, M., Enders, G. H., Wu, C. L., Su, L. K., Gorka, C., Nelson, C., Harlow, E., & Tsai, L. H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05360.x · Cited by 923
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
Research works printed but not linked: 2
- Motokura, T. & Arnold, A. Biochim. biophys. Acta 1155, 63–78 (1993).
- Lukas, J., Pagano, M., Staskova, Z., Draetta, G. & Bartek, J. Oncogene (in the press).
Cited by
Items 701–800 of 1,022
Mælandsmo, G., Flørenes, V., Hovig, E., Øyjord, T., Engebraaten, O., Holm, R., Børresen, A.-L., & Fodstad, Ø. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.181 · Cited by 106
“The following probes were used: CCNDJ cDNA kindly provided by Dr D Beach, Howard Hughes Medical Institute, Cold Spring Harbor, NY, USA, and CDK4 cDNA by Dr P Meltzer, National Institutes of Health, Bethesda, MD, USA.”
BackgroundMethodResultInfluentialGenomic Alterations of the p19ARF Encoding Exons in T-Cell Acute Lymphoblastic Leukemia
Gardie, B., Cayuela, J.-M., Martini, S., & Sigaux, F. (1998) · Blood · doi:10.1182/blood.v91.3.1016 · Cited by 106
Zhou, Y., Zeng, Z., Zhang, W., Xiong, W., Wu, M., Tan, Y., Yi, W., Xiao, L., Li, X., Huang, C., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23727 · Cited by 110
Ramirez, R. D., Herbert, B., Vaughan, M. B., Zou, Y. S., Gandia, K., Morales, C. P., Wright, W. E., & Shay, J. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206046 · Cited by 119
“Upregulation of endogenous p16INK4a in overexpressingCdk4 cells cultured on plastic Since p16INK4a binds Cdk4 and prevents its interaction with cyclin D (Serrano et al., 1993; Coleman et al., 1997), we reasoned that overexpressing Cdk4 would titer out p16INK4a and permit ongoing cell divisions.”
BackgroundStraume, O., Smeds, J., Kumar, R., Hemminki, K., & Akslen, L. A. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64174-0 · Cited by 124
Carbonara, C., Longa, L., Grosso, E., Mazzucco, G., Borrone, C., Garrè, M. L., Brisigotti, M., Filippi, G., Scabar, A., Giannotti, A., et al. (1996) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199601)15:1<18::aid-gcc3>3.0.co;2-7 · Cited by 131
Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review)
Kobayashi (2009) · Oncology Reports · doi:10.3892/or_00000429 · Cited by 115
Tumor suppressor genes and related molecules in leiomyosarcoma.
Tos, A. P. D., Maestro, R., Doglioni, C., Piccinin, S., Libera, D. D., Boiocchi, M., & Fletcher, C. D. �. (1996) · Europe PMC (PubMed Central) · Cited by 105
TUMOR SUPPRESSOR GENE MUTATIONS IN MICE
Jacks, T. (1996) · Annual Review of Genetics · doi:10.1146/annurev.genet.30.1.603 · Cited by 105
p16 and p21WAF1 Protein Expression in Melanocytic Tumors by Immunohistochemistry
Sparrow, L. E., Eldon, M. J., English, D. R., & Heenan, P. J. (1998) · The American Journal of Dermatopathology · doi:10.1097/00000372-199806000-00006 · Cited by 105
Nasmyth, K., & Hunt, T. (1993) · Nature · doi:10.1038/366634a0 · Cited by 105
Regulation of CDK4 activity by a novel CDK4-binding protein, p34SEI-1
Sugimoto, M., Nakamura, T., Ohtani, N., Hampson, L., HAMPSON, I. N., Shimamoto, A., Furuichi, Y., Okumura, K., Niwa, S., Taya, Y., et al. (1999) · Genes & Development · doi:10.1101/gad.13.22.3027 · Cited by 122
Genetic and epigenetic changes in stomach cancer
Yokozaki, H., Yasui, W., & Tahara, E. (2001) · International review of cytology · doi:10.1016/s0074-7696(01)04003-7 · Cited by 112
Maruo, S., Wu, Y., Ishikawa, S., Kanda, T., Iwakiri, D., & Takada, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604919104 · Cited by 104
Zhang, J., Zhao, X., Wei, Q., & Paterson, B. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.6983 · Cited by 121
“The cdk4-specific kinase inhibitor p16 (from D.Beach; Serrano et al., 1993) was used as a GST–p16 fusion added to the kinase reaction.”
BackgroundMethodChaudru, V., Chompret, A., Bressac-de Paillerets, B., Spatz, A., Avril, M.-F., & Demenais, F. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh136 · Cited by 104
“The alpha transcript encodes the p16INK4A protein, which inhibits the activity of the cyclin D1-CDK4 complex, preventing the cell from progressing through the G1 cell cycle checkpoint and therefore acting as a tumor suppressor ( 6 ,7).”
BackgroundSiavoshian, S., Blottière, H. M., Cherbut, C., & Galmiche, J. P. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6255 · Cited by 103
Site specificity and mechanism of oxidative DNA damage induced by carcinogenic catechol
Oikawa, S. (2001) · Carcinogenesis · doi:10.1093/carcin/22.8.1239 · Cited by 105
Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems
Medina, D., & Santisteban, P. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430161 · Cited by 105
Fizzotti, M., Cimino, G. G., Pisegna, S., Alimena, G., Quartarone, C., Mandelli, F., Pelicci, P. G., & Coco, F. L. (1995) · Blood · doi:10.1182/blood.v85.10.2685.bloodjournal85102685 · Cited by 110
“^ and (2) the direct involvement of p16 in cell cycle regulation? In the present study, we report homozygous deletions of p16 in a sizable fraction of ALL cases.”
BackgroundFinding prospective partners in the library: the two-hybrid system and phage display find a match
Allen, J. B., Walberg, M. W., Edwards, M. C., & Elledge, S. J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89119-7 · Cited by 126
Ogawa, S., Hangaishi, A., Miyawaki, S., Hirosawa, S., Miura, Y., Takeyama, K., Kamada, N., Ohtake, S., Uike, N., & Shimazaki, C. (1995) · Blood · doi:10.1182/blood.v86.4.1548.bloodjournal8641548 · Cited by 107
MOZ is fused top300 in an acute monocytic leukemia with t(8;22)
Chaffanet, M., Gressin, L., Preudhomme, C., Soenen, V., Birnbaum, D., & P�busque, M.-J. (2000) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200006)28:2<138::aid-gcc2>3.0.co;2-2 · Cited by 184
Li, X., Hui, A., Sun, L., Hasegawa, K., Torzilli, G., Minagawa, M., Takayama, T., & Makuuchi, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1715 · Cited by 105
Kees, U. R., Burton, P. R., Lü, C., & Baker, D. L. (1997) · Blood · doi:10.1182/blood.v89.11.4161 · Cited by 109
Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives
Greco, O., & Dachs, G. U. (2001) · Journal of Cellular Physiology · doi:10.1002/1097-4652(2001)9999:9999<::aid-jcp1060>3.0.co;2-h · Cited by 273
Yeast Two-hybrid System Demonstrates That Estrogen Receptor Dimerization Is Ligand-dependent in Vivo
Wang, H., Peters, G. A., Zeng, X., Tang, M., Ip, W., & Khan, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23322 · Cited by 105
Rots, N. Y., Iavarone, A., Bromleigh, V. C., & Freedman, L. P. (1999) · Blood · doi:10.1182/blood.v93.8.2721 · Cited by 114
Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Liloglou, T., Kyroudi, A., Veslemes, M., Rassidakis, A., Halazonetis, T. D., Field, J. K., & Kittas, C. N. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65690-8 · Cited by 113
“Serrano et al has proposed a negative feedback model, showing that inactivation of pRb during G1 leads to increased p16 expression to limit CDK4 activity.(4) Moreover, several studies in various tumors, including NSCLCs, have demonstrated a reciprocal relationship between pRb and p16.”
BackgroundTakino, H., Li, C., Hu, S., Kuo, T., Geissinger, E., Müller‐Hermelink, H. K., Kim, B.-C., Swerdlow, S. H., & Inagaki, H. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.159 · Cited by 103
“36 The p16 gene encodes for nuclear protein that can block cell-cycle progression from the G 1 to the S phase by effectively inhibiting the kinase activity of CDK4s6, thereby exerting a negative control on cell proliferation”
BackgroundLiu, L., Broaddus, R. R., Yao, J. C., Xie, S.-S., White, J. A., Wu, T., Hamilton, S. R., & Rashid, A. (2005) · Modern Pathology · doi:10.1038/modpathol.3800490 · Cited by 112
“13 p16 inhibition of cyclin-dependent kinase 4 (CDK4) causes retinoblastoma protein to stay in its active form and arrest the cell cycle at G1–S transition”
BackgroundXiao, Y., Monitto, C. L., Minhas, K. M., & Sidransky, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0988 · Cited by 106
Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas
Pallante, P., Visone, R., Croce, C. M., & Fusco, A. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0217 · Cited by 111
Involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation
Tian, J. Q., & Quaroni, A. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.6.c1245 · Cited by 110
“Immunoprecipitates obtained with antibodies directed against the three CKIs, cyclin D, or cyclin E were sequentially immunoblotted with antibodies specific for Cdk2, Cdk4, Cdk6, and cyclins A, E, D1, D2, and D3.”
BackgroundInfluentialPinyol, M., Hernández, L., Martínez, A., Cobo, F., Hernandez, S. F., Beà, S., López‐Guillermo, A., Nayach, I., Palacín, A., Nadal, A., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65071-7 · Cited by 107
“The p53 pathway induces growth arrest or apoptosis in response to DNA damage and other stimuli of cellular distress,(4) whereas p16 participates in the control of the G1 phase by inhibiting the kinase activity of CDK4/6 and, consequently, the phosphorylation status of retinoblastoma protein (Rb).(5) The recent underst…”
BackgroundYOSHIZUMI, M., Lee, W. S., Hsieh, C.-M., Tsai, J. C.-S., Li, J., Perrella, M. A., Patterson, C., Endege, W. O., Schlegel, R., & Lee, M. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117918 · Cited by 102
Aagaard, L., Lukas, J., Bartkova, J., Kjerulff, A., Strauss, M., & Bartek, J. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610120 · Cited by 102
Maelandsmo, G., Berner, J.-M., Flørenes, V., Forus, A., Hovig, E., Fodstad, Ø., & Myklebost, O. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.344 · Cited by 102
Hirst, K. L., Fisher, F. A., McAndrew, P. C., & Goding, C. R. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06876.x · Cited by 102
Deletions and rearrangement of CDKN2 in lymphoid malignancy
Stranks, G., Height, S., Mitchell, P. L. R., Jadayel, D. M., Ma, Y., Lord, C., Clutterbuck, R. D., Treleaven, J., Powles, R. L., & Nacheva, E. P. (1995) · Blood · doi:10.1182/blood.v85.4.893.bloodjournal854893 · Cited by 107
p53-Dependent and -Independent Functions of the Arf Tumor Suppressor
SHERR, C. J., BERTWISTLE, D., DEN BESTEN, W., KUO, M.-L., SUGIMOTO, M., TAGO, K., WILLIAMS, R. T., ZINDY, F., & ROUSSEL, M. F. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.004 · Cited by 101
“The founding member of the INK4 gene family, INK4a (Serrano et al. 1993), is one of four genes whose encoded products act in a biochemically similar manner to inhibit the Cdk4 and Cdk6 kinases (Roussel 1999; Ortega et al.”
BackgroundRole of cyclooxygenase-2 in gastric cancer development and progression
Cheng, J., & Fan, X.-M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i42.7361 · Cited by 100
Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas
Renner, M., Wolf, T. A., Meyer, H. V., Hartmann, W., Penzel, R., Ulrich, A. B., Lehner, B., Hovestadt, V., Czwan, E., Egerer, G., et al. (2013) · Genome biology · doi:10.1186/gb-2013-14-12-r137 · Cited by 106
“The p16INK4A protein product of the CDKN2A locus is known to be an important tumor-suppressor gene, which directly inhibits the kinases encoded by the oncogenes CDK4 and CDK6 [54,55].”
BackgroundCellular senescence and tumor promotion: Is aging the key?
Loaiza, N., & Demaria, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.007 · Cited by 101
Tian, X., Azpurua, J., Ke, Z., Augereau, A., Zhang, Z. D., Vijg, J., Gladyshev, V. N., Gorbunova, V., & Seluanov, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418203112 · Cited by 101
“The p16 and p15 proteins are cyclin-dependent kinase inhibitors that directly inhibit the binding of cyclins to their target cyclin-dependent kinases (10).”
BackgroundBerggren, P., Kumar, R., Sakano, S., Hemminki, L., Wada, T., Steineck, G., Adolfsson, J., Larsson, P., Norming, U., Wijkström, H., et al. (2003) · PubMed · Cited by 114
Alterations of the p15, p16, and p18 genes in osteosarcoma
Miller, C. W., Aslo, A., Campbell, M. J., Kawamata, N., Lampkin, B. C., & Koeffler, H. P. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(95)00216-2 · Cited by 116
Regulatory Role of p27kip1 in the Mouse and Human Testis
Beumer, T. L., Kiyokawa, H., Roepers‐Gajadien, H. L., van den Bos, L. A. C., Lock, T., Gademan, I. S., Rutgers, D. H., Koff, A., & de Rooij, D. G. (1999) · Endocrinology · doi:10.1210/en.140.4.1834 · Cited by 112
Differential CDK-inhibitor gene expression in aging human diploid fibroblasts
Wong, H., & Riabowol, K. T. (1996) · Experimental Gerontology · doi:10.1016/0531-5565(95)00025-9 · Cited by 114
Mirghani, H., Amen, F., Moreau, F., Guigay, J., Ferchiou, M., Melkane, A. E., Hartl, D. M., & Guily, J. L. S. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.10.008 · Cited by 112
“2) [60].”
Dai, M., Al-Odaini, A. A., Fils-Aimé, N., Villatoro, M. A., Guo, J., Arakelian, A., Rabbani, S. A., Ali, S., & Lebrun, J. J. (2013) · Breast Cancer Research · doi:10.1186/bcr3441 · Cited by 100
“The INK4 family, which includes p15INK4, p16INK4A, p18INK4C and p19INK4D, specifically binds to CDK4 and 6, thereby preventing their association with the D-type cyclins [26-29].”
BackgroundPatel, V., Lahusen, T. J., Sy, T. H., Sausville, E. A., Gutkind, J. S., & Senderowicz, A. M. (2002) · PubMed · Cited by 99
Identification of CDK4 Sequences Involved in Cyclin D1 and p16 Binding
Coleman, K. G., Wautlet, B. S., Morrissey, D., Mulheron, J., Sedman, S. A., Brinkley, P., Price, S., & Webster, K. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18869 · Cited by 100
Ai, L., Stephenson, K. K., Ling, W., Zuo, C., Mukunyadzi, P., Suen, J. Y., Hanna, E. Y., & Fan, C. (2003) · Modern Pathology · doi:10.1097/01.mp.0000085760.74313.dd · Cited by 113
“The tumor suppressor function of p16 is attributed to its ability to inhibit the catalytic activity of the cyclin-dependent kinase 4 – 6/cyclin D complex that is required for phosphorylation of retinoblastoma protein (5, 6).”
Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells
Волгарева, Г. М., Эдуардовна, З. Л., Andreeva, Y. Y., Frank, G. A., Крутікова, Е. І., Golovina, D., Bliev, A., Spitkovsky, D., Ermilova, V. D., & Kisseljov, F. L. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-58 · Cited by 112
“This protein belongs to the group of cyclin-dependent kinase Cdk4/6 inhibitors [17] and is encoded by tumor suppressor gene INK 4a (synonyms: MTS 1, CDKN2, INK4a/ARF).”
BackgroundCell Senescence and Its Implications for Nephrology
MELK, A., & HALLORAN, P. F. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v122385 · Cited by 101
Kudo, Y., Takata, T., Ogawa, I., Kaneda, T., Sato, S., Takekoshi, T., Zhao, M., Miyauchi, M., & Nikai, H. (2000) · PubMed · Cited by 108
Current Concepts in Neuro-Oncology: The Cell Cycle-A Review
Dirks, P. B., & Rutka, J. T. (1997) · Neurosurgery · doi:10.1097/00006123-199705000-00025 · Cited by 115
The Molecular Epidemiology of Lung Cancer
Spivack, S. D., Fasco, M. J., Walker, V. E., & Kaminsky, L. S. (1997) · Critical Reviews in Toxicology · doi:10.3109/10408449709089898 · Cited by 96
Arf induces p53-dependent and -independent antiproliferative genes.
Kuo, M.-L., Duncavage, E. J., Mathew, R., den Besten, W., Pei, D., Naeve, D., Yamamoto, T. S., Cheng, C., Sherr, C. J., & Roussel, M. F. (2003) · PubMed · Cited by 121
Svensson, S., Nilsson, K., Ringberg, A., & Landberg, G. (2003) · PubMed · Cited by 108
Epigenetic Inactivation of Tumor Suppressor Genes in Serum of Patients with Cutaneous Melanoma
Marini, A., Mirmohammadsadegh, A., Nambiar, S., Gustrau, A., Ruzicka, T., & Hengge, U. R. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700073 · Cited by 109
“The p16 gene encodes a protein, P16, which is a D-type cyclin-dependent kinase inhibitor that blocks the ability of CDK4 to interact with cyclin D and stimulate the progression of eukaryotic cells through the G1 phase of the cell cycle (Serrano et al., 1993).”
BackgroundIkuta, M., Kamata, K., Fukasawa, K., Honma, T., Machida, T., Hirai, H., Suzuki-Takahashi, I., Hayama, T., & Nishimura, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102060200 · Cited by 99
Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines
Jonuleit, T., van der Kuip, H., Miething, C., Michels, H., Hallek, M., Duyster, J., & Aulitzky, W. E. (2000) · Blood · doi:10.1182/blood.v96.5.1933 · Cited by 99
Role of Cyclin-Dependent Kinases and Their Inhibitors in Cellular Differentiation and Development
Chellappan, S., Giordano, A., & Fisher, P. B. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71941-7_4 · Cited by 102
Stubdal, H., Zalvide, J. B., & DeCaprio, J. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.2781-2788.1996 · Cited by 106
“It has been suggested that p16 may become induced because TAg causes the cell to become functionally pRb deficient and that the cell responds by attempting to block pRb phosphorylation by inhibiting the RB kinase, cdk4, by overexpressing p16 (54).”
BackgroundCell-cycle control and renal disease
Shankland, S. J. (1997) · Kidney International · doi:10.1038/ki.1997.335 · Cited by 103
Alteration of pRb/p16/cdk4 regulation in human osteosarcoma
Benassi, M. S., Molendini, L., Gamberi, G., Ragazzini, P., Sollazzo, M. R., Merli, M., Asp, J., Magagnoli, G., Balladelli, A., Bertoni, F., et al. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991022)84:5<489::aid-ijc7>3.0.co;2-d · Cited by 115
Posttranslational modifications of histone deacetylases: Implications for cardiovascular diseases
Eom, G. H., & Kook, H. Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.012 · Cited by 105
Human cyclin D1 oncogene and esophageal squamous cell carcinoma
Nakagawa, H., Zukerberg, L. R., Togawa, K., Meltzer, S. J., Nishihara, T., & Rustgi, A. K. (1995) · Cancer · doi:10.1002/1097-0142(19950815)76:4<541::aid-cncr2820760402>3.0.co;2-i · Cited by 103
p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro.
Liggett, W. H., Sewell, D. A., Rocco, J., Ahrendt, S. A., Koch, W. M., & Sidransky, D. (1996) · PubMed · Cited by 114
Sasaguri, T., Ishida, A., Kosaka, C., Nojima, H., & Ogata, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8345 · Cited by 99
Emig, R., Magener, A., Ehemann, V, Meyer, A., Stilgenbauer, F., Volkmann, M., Wallwiener, D., & Sinn, H. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.739 · Cited by 97
“All tumours were classified according to the AFIP classification for brast carinomas (Rosen and Oberman, 1992) and staged acoding to the TNM system (UICC, 1992) (for details see Table 1).”
MethodMolecular genetic basis of pancreatic adenocarcinoma
Hilgers, W., & Kern, S. E. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199909)26:1<1::aid-gcc1>3.0.co;2-x · Cited by 105
“p16 is an inhibitor of the cyclinD-Cdk4 and cyclinD-Cdk6 mitotic kinase complexes that downregulate the activity of the cell cycle inhibitor protein Rb (Serrano et al., 1993).”
BackgroundThe molecular biology of oral carcinogenesis: Toward a tumor progression model
Todd, R., Donoff, R. B., & Wong, D. T. (1997) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(97)90495-x · Cited by 128
Arresting developments in the cardiac myocyte cell cycle: Role of cyclin-dependent kinase inhibitors
Brooks, G., Poolman, R. A., & Li, J. M. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00125-4 · Cited by 113
Structure of the cyclin-dependent kinase inhibitor p19Ink4d
Luh, F. Y., Archer, S. J., Domaille, P. J., Smith, B. O., Owen, D., Brotherton, D. H., Raine, A. R. C., Xu, X., Brizuela, L., Brenner, S. L., et al. (1997) · Nature · doi:10.1038/40202 · Cited by 114
Wang, H., Chen, J., Xu, C., Shi, L., Tayier, M., Zhou, J., Zhang, J., Wu, J., Ye, Z., Fang, T., et al. (2017) · Theranostics · doi:10.7150/thno.20028 · Cited by 98
“CDK1 is negatively regulated by p21, a CDK1 inhibitor [56].”
BackgroundChilosi, M., Doglioni, C., Yan, Z., Lestani, M., Menestrina, F., Sorio, C., Benedetti, A., Vinante, F., Pizzolo, G., & Inghirami, G. (1998) · Europe PMC (PubMed Central) · Cited by 96
The role of p53 in pigmentation, tanning and melanoma
Box, N. F., & Terzian, T. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00495.x · Cited by 96
“p16 is a CDK4associated protein that inhibits CDK4/6-mediated phosphorylation of the retinoblastoma tumor suppressor (pRb) (Serrano et al., 1993) resulting in cell cycle arrest.”
BackgroundFerreiro, D. U., Cho, S. S., Komives, E. A., & Wolynes, P. G. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.078 · Cited by 105
“p16 is a naturally occurring ankyrin repeat protein, whose primary function is related to cell cycle progression, by interacting and inhibiting Cdk6 and Cdk4.”
BackgroundHistone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter
Yokota, T., Matsuzaki, Y., Miyazawa, K., Zindy, F., Roussel, M. F., & Sakai, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207689 · Cited by 102
“The four members of the INK4 family, designated as p16INK4a, p15INK4b, p18INK4c and p19INK4d, specifically and directly bind to CDK4/6 and inhibit their activity (Serrano et al., 1993; Hirai et al., 1995; Sherr and Roberts, 1999).”
BackgroundKim, K. S., Sack, J. S., Tokarski, J. S., Qian, L., Chao, S. T., Leith, L. W., Kelly, Y. F., Misra, R. N., Hunt, J. T., Kimball, S. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000231g · Cited by 104
Molecular foundations of cancer: New targets for intervention
Karp, J. E., & Broder, S. E. (1995) · Nature Medicine · doi:10.1038/nm0495-309 · Cited by 111
Environmental risk factors and epigenetic alternations in psoriasis
Roszkiewicz, M., Dopytalska, K., Szymańska, E., Jakimiuk, A. J., & Walecka, I. (2019) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/112107 · Cited by 129
“Protein p16INK4a negatively regulates CDK4 and CDK6 proteins, which promotes progression from G1 to S phase in the cell growth cycle [24].”
BackgroundMolecular mechanisms of pancreatic carcinogenesis
Furukawa, T., Sunamura, M., & Horii, A. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2005.00134.x · Cited by 96
Cao, J., Zhou, J., Gao, Y., Gu, L., Meng, H., Liu, H., & Deng, D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0580 · Cited by 95
Scaglione-Sewell, B., Bissonnette, M., Skarosi, S. F., Abraham, C., & Brasitus, T. A. (2000) · Endocrinology · doi:10.1210/endo.141.11.7782 · Cited by 95
Alteration of p16 and p15 genes in human uterine tumours
Nakashima, R., Fujita, M., Enomoto, T., Haba, T., Yoshino, K., Wada, H., Kurachi, H., Sasaki, M., Wakasa, K., Inoue, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690379 · Cited by 105
“…of the cell cy Specific binding of p16 protein to the CDK4 or CDK6 cycli dependent protein kinases inhibits the phosphorylation activit CDK–cyclin D complexes towards the nuclear RB/E2F prot complex (Serrano et al, 1993). p16 normally prevents phosph ation of RB, resulting in RB’s retention of E2F.”
BackgroundSakorafas, G. H., Tsiotou, A. G., & Tsiotos, G. G. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0144 · Cited by 103
CDK2 Is a Target for Retinoic Acid-Mediated Growth Inhibition in MCF-7 Human Breast Cancer Cells
Teixeira, C., & Pratt, M. A. C. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.9.9977 · Cited by 100
Nip, J., Strom, D. K., Fee, B. E., Zambetti, G., Cleveland, J. L., & Hiebert, S. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1049 · Cited by 95
Emerging roles of RB family: New defense mechanisms against tumor progression
Indovina, P., Marcelli, E., Casini, N., Rizzo, V., & Giordano, A. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24170 · Cited by 100
“…activity inhibition by p27 in RB1/p105-induced senescence. p16, a tumor suppressor encoded by the CDKN2A locus, is themajor positive regulator of RB1/p105. p16 inhibits the binding between cyclin D and CDK4/6 and thereby prevents phosphorylation and inactivation of RB1/p105 (Serrano et al., 1993).”
BackgroundEarly Vascular Ageing and Cellular Senescence in Chronic Kidney Disease
Dai, L., Qureshi, A. R., Witasp, A., Lindholm, B., & Stenvinkel, P. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.06.015 · Cited by 94
Hydroxyurea Induces Site‐specific DNA Damage via Formation of Hydrogen Peroxide and Nitric Oxide
Sakano, K., Oikawa, S., Hasegawa, K., & Kawanishi, S. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb02136.x · Cited by 96
Nakanishi, Y., Zen, Y., Kondo, S., Itoh, T., Itatsu, K., & Nakanuma, Y. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.11.018 · Cited by 98
“p16 and p21, both of which are CDK inhibitors, can prevent cell cycle progression at the G1-S checkpoint by binding to cyclin D1/CDK complexes [4].”
BackgroundThe significance of telomerase activation and cellular immortalization in human cancer
Newbold, R. F. (2002) · Mutagenesis · doi:10.1093/mutage/17.6.539 · Cited by 100
“The encoded suppressor protein (and other related INK4 family members) binds to cyclin-dependent kinases cdk-4 and cdk-6 (Serrano et al., 1993) and, by blocking their association with D-type cyclins, induces cell cycle arrest by preventing phosphorylation of pRB; p16 therefore lies upstream of pRB and loss of function…”
BackgroundAlterations of pRb1-cyclin D1-cdk4/6-p16INK4A pathway in endometrial carcinogenesis
Semczuk, A., & Jakowicki, J. A. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.09.012 · Cited by 104
“[16] M.”
BackgroundInfluentialCayuela, J., Madani, A., Sanhes, L., Stern, M., & Sigaux, F. (1996) · Blood · doi:10.1182/blood.v87.6.2180.bloodjournal8762180 · Cited by 94
“D A corresponding t o the wild sequence (1) and the mu-”
BackgroundMethodInfluentialTwo arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization
Rizos, H., Darmanian, A., Mann, G. J., & Kefford, R. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203629 · Cited by 106
“…role in maintaining cell cycle control; p16INK4a regulates G1phase exit by inhibiting the phosphorylation of the retinoblastoma protein (pRb) (Serrano et al., 1993) and p14ARF acts via p53 to induce cell cycle arrest (Stott et al., 1998; Kamijo et al., 1998) in response to hyperproliferative…”
Background
Metadata
- Authors
- Serrano, M., Hannon, G. J., & Beach, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Hannon, Gregory J.
- Venue
- Nature
- Published
- 1993-12
- Volume
- 366
- Issue
- 6456
- Pages
- 704-707
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2066848701
- Cited by
- 3,650
- References
- 22
- Citations by year
- 2026: 36 · 2025: 46 · 2024: 52 · 2023: 66 · 2022: 67 · 2021: 78 · 2020: 64 · 2019: 63 · 2018: 56 · 2017: 70 · 2016: 69 · 2015: 75 · 2014: 52 · 2013: 98 · 2012: 88
- FWCI
- 78.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p16, CDK4, cyclin D, cyclin-dependent kinases, cell cycle regulation, G1 phase, kinase inhibition, retinoblastoma protein, p21, proliferating cell nuclear antigen, feedback regulation, cell proliferation
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Cycle, Cloning, Molecular, DNA, Glutathione Transferase, HeLa Cells, Humans, Molecular Sequence Data, Phosphorylation, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Saccharomyces cerevisiae, Oncogene Proteins, Retinoblastoma Protein, Cyclins, Cyclin-Dependent Kinases, Cyclin D1, Cyclin-Dependent Kinase Inhibitor p16, Protein Kinase Inhibitors, Cyclin-Dependent Kinase 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.